Browse by author
Lookup NU author(s): Dr Petros PerrosORCiD, David Mason, Professor Mark PearceORCiD, Professor Simon PearceORCiD, Dr Ujjal Mallick
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020 John Wiley & Sons Ltd. Objective: Mortality from thyroid cancer is reported to be higher in the UK compared with several other European countries, though UK data on mortality by disease stage have not been published. The aim of this study was to ascertain disease-specific mortality by stage in our centre. Design, patients and measurements: This was a cohort study of all patients presenting to a single centre. Four hundred and twenty patients treated between 2000 and 2010 were identified. The medical records and causes of deaths were reviewed and analysed. Results: Overall disease-specific mortality at 5 and 10 years was 1.4% and 5.8%, respectively. The observed mortality was 58 against 66.3 expected deaths (CI 43.8-75.4) thus yielding an age-standardized mortality rate of 0.87. There were no deaths due to thyroid cancer in patients with stage I disease at 5 or 10 years. The 10-year disease-specific mortality rose with stage (stage II 3.1%, stage III 28.6%, stage IV 30%). Conclusions: Thyroid cancer mortality of patients treated at our centre was lower than the official national UK registry and most European figures.
Author(s): Perros P, Mason D, Pearce M, Pearce SHS, Chandler R, Mallick UK
Publication type: Article
Publication status: Published
Journal: Clinical Endocrinology
Year: 2020
Volume: 93
Issue: 1
Pages: 61-66
Print publication date: 01/07/2020
Online publication date: 04/04/2020
Acceptance date: 19/03/2020
ISSN (print): 0300-0664
ISSN (electronic): 1365-2265
Publisher: John Wiley & Sons Ltd
URL: https://doi.org/10.1111/cen.14187
DOI: 10.1111/cen.14187
PubMed id: 32248544
Altmetrics provided by Altmetric
